Stay updated on Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Sign up to get notified when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Locations section updated to include Queensland and Victoria as study sites; the page revision updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:50:57.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The Publications section now clarifies that PubMed-sourced publications are auto-filled and linked to the NCT number. It specifies the origin of these entries and how they relate to the study record.
    Difference
    0.1%
    Check dated 2025-11-25T13:35:37.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page, which previously stated that information may not be up to date and that the agency may not respond until appropriations are enacted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:22:20.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The Study Details page appears unchanged between the two screenshots; no new or removed information was detected.
    Difference
    0.5%
    Check dated 2025-11-03T21:26:13.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Major update: announces a funding-related operating status notice and a new version v3.2.0; replaces the earlier v3.1.0 release.
    Difference
    3%
    Check dated 2025-10-06T07:00:57.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:49:29.000Z thumbnail image

Stay in the know with updates to Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.